Gene Expression Profiles of K-ras Activated Mutation in Non-Small Cell Lung Cancer
碩士 === 高雄醫學大學 === 醫學研究所碩士班 === 94 === The biomarkers of lung cancer that can significantly affect the prognosis of the patients and the effectiveness of anti-cancer drug therapy are (1) K-ras mutation (2) EGFR mutation (3) biomarkers of neuroendocrine features. From literature review, we know that t...
Main Authors: | Cheng-Yuan Wang, 王程遠 |
---|---|
Other Authors: | 黃明賢 |
Format: | Others |
Language: | zh-TW |
Published: |
2006
|
Online Access: | http://ndltd.ncl.edu.tw/handle/48775143523841920001 |
Similar Items
-
K-RAS Gene Mutations in Patients with Non-small Cell Lung Cancer
by: Yang ZHANG, et al.
Published: (2010-06-01) -
Study on Point Mutations of K-ras Gene in Non-small Cell Lung Cancer in Guangxi
by: Weixiang ZHONG, et al.
Published: (2011-06-01) -
Study of the Correlation of EGFR and K-RAS Gene Mutations with Its Protein Expression in Non-small Cell Lung Cancer
by: Huan-ling LUAN, et al.
Published: (2010-04-01) -
Ras gene mutations in patients with non-small cell lung carcinoma
by: Minić Vesna, et al.
Published: (2004-01-01) -
The Role of DREAM/MMB-mediated mitotic gene expression downstream of mutated K-Ras in lung cancer
by: Iltzsche, Fabian
Published: (2017)